Loading…
Inmed, a resident of the St. Petersburg special economic zone, has laid the foundation for a new research and production complex in Neudorf. The company plans to produce hemostatic agents and nanomembranes, with total investment exceeding 1.6 billion rubles. Construction is expected to take 18 months, with launch in 2019.
“Компания планирует производить новые материалы на основе полимерных нановолокон, большая часть из которых будет использоваться военными в медицинских целях.”kommersant.ru
Summarized from public sources; check the original articles before acting on it.